Pilot Trial Links Reduced Ultra-Processed Food Intake to Lower Depression Symptoms
A recent pilot trial conducted by researchers at the University of California, San Francisco (UCSF) has explored the relationship between ultra-processed food consumption and depression symptoms. The study involved 20 adults diagnosed with depression, who were recruited based on their significant intake of ultra-processed foods. Participants, with an average age of 44 and an average history of depression lasting nearly 13 years, were randomly assigned to follow one of two dietary patterns for four weeks each. One group maintained their usual diet, while the other reduced their intake of ultra-processed foods. After the first four weeks, the groups switched diets to allow for a direct comparison of the effects.
Throughout the trial, participants were instructed to purchase their own food while receiving guidance from the researchers. They were asked to keep their medications, therapy, exercise, and sleep routines unchanged to isolate the dietary variable. Nineteen participants completed the study, and results indicated a substantial decrease in the consumption of ultra-processed foods, with average scores on a food consumption questionnaire dropping from 10.10 at baseline to 1.42 after the dietary intervention.
The researchers conducted three separate assessments of depression symptoms during the trial. The PHQ-9 assessment showed average scores of 8.68 during the usual diet compared to 5.53 during the low-ultra-processed-food diet, indicating a notable improvement. Similarly, the MADRS assessment revealed average scores of 18.9 during the usual diet and 8.05 during the dietary intervention. Participants also reported lower scores on an anxiety questionnaire during the low-ultra-processed-food period.
Previous observational studies have suggested a correlation between high consumption of ultra-processed foods and increased depression symptoms. This trial aimed to investigate the effects of dietary changes on individuals already experiencing depression. However, the researchers noted that reducing ultra-processed food intake can be challenging due to its convenience, taste, and affordability.
Participants rated the ease of adhering to the dietary intervention at an average of 5.74, while its perceived usefulness received a higher average rating of 8.42. Importantly, no adverse events were reported during the study, suggesting the dietary change was both feasible and acceptable for participants.
While the findings indicate a potential link between reduced ultra-processed food consumption and improved depression symptoms, the study's limitations must be acknowledged. The trial was small and unblinded, meaning participants were aware of the dietary changes, which could have influenced their expectations and responses. Additionally, food consumption was self-reported without objective measures of ultra-processed food intake. All participants had high body weight and at least one metabolic abnormality, which may limit the generalizability of the findings to the broader population of individuals with depression.
The primary outcomes of this pilot study focused on feasibility and acceptability, with the depression and anxiety outcomes being exploratory in nature. The researchers emphasize the need for larger, blinded studies that utilize objective measures of ultra-processed food intake and further investigate the underlying mechanisms of these observed effects. The research findings have been published in JAMA Psychiatry.




